Lung-MAP S1400K: c-MET Positive

NCT03574753 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Squamous Cell Lung Carcinoma
Stage IV Squamous Cell Lung Carcinoma AJCC V7

Interventions

DRUG: ABBV-399

Sponsor

SWOG Cancer Research Network